Thank you so much for your response to my question. I don't know where to turn since my provider isn't very knowledgeable about this, so maybe you can help me with this, as I'm thinking of changing to Menostar from Vivelle-dot. The data I have is:
Menostar (estradiol transdermal system) 14 mcg per day - each 3.25 cm2 system contains 1 mg of estradiol.
Vivelle-Dot® (estradiol transdermal system), 0.025 mg/day - each 2.5 cm² system contains 0.39 mg of estradiol USP for nominal* delivery of 0.025 mg of estradiol per day.
Since the Menostar patch is applied once/weekly and contains 1 mg of estradiol, then that's around .14 mg/day (the data says .014 mg/day). The Vivelle-dot is applied twice/weekly and contains .39 mg estradiol, which is .78 mg estradiol/week which is around .11 mg/day (data says .025 mg/day). This is what is confusing me. According to my calculations, Menostar delivers .14 mg/day and Viville-dot delivers .11 mg/day (which is less than Menostar). That's not what the data says though, but when I do the calculations, I come out with different answers. I'm just trying to take the lowest dose I need for osteoporosis protection (since I have osteoporosis). Thanks so much. I know this comment is boring!
Hello,
Several studies have already shown that lower-than-standard doses of hormone therapy can relieve menopausal symptoms and prevent bone loss. Menostar is an ultra, ultra low-dose estrogen patch (0.014 mg/day) that has recently been approved for unopposed estrogen use in postmenopausal women. It is indicated for bone protection only and does not offer any vasomotor symptom relief.
You can get these patches prescribed.
It is very difficult to precisely confirm a diagnosis without examination and investigations and the answer is based on the medical information provided. For exact diagnosis, you are requested to consult your doctor. I sincerely hope that helps. Take care and please do keep me posted on how you are doing.